Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: Results from the prospective, multicentre, Mona Lisa cohort study

European Heart Journal

Volumn 30, Issue 10, 2009, Pages 1237-1244

  Boveda, Serge ^a   Marijon, Eloi ^a   Jacob, Sophie ^b   Defaye, Pascal ^c   Winter, Jobst B ^d   Bulava, Alan ^e   Gras, Daniel ^f   Albenque, Jean Paul ^a   Combes, Nicolas ^a   Pavin, Dominique ^g   Delarche, Nicolas ^h   Teubl, Alexander ⁱ   Lambiez, Marie ^j   Chevalier, Philippe ^k,l  

^a CLINIQUE PASTEUR   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d CPRLab   (Netherlands)

^e UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^f Nouvelles Cliniques Nantaises   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h HÔPITAL DU BOCAGE   (France)

ⁱ Guidant ^*  (Austria)

^j Guidant   (France)

^k UNIVERSITÉ DE LYON   (France)

^l UNIVERSITÉ LYON 1   (France)

more..

Author keywords

Cardiac resynchronization therapy; Electrograms; Heart failure; Incidence; Ventricular tachycardia

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH;

AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROGNOSIS; TACHYCARDIA, VENTRICULAR;

EID: 66249091584     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp071     Document Type: Article

References (29)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140- 2150.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronisation on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
3. Daubert JC, Leclercq C, Mabo P. There is plenty of room for cardiac resynchronisation therapy devices without back-up defibrillators in the electrical treatment of heart failure. J Am Coll Cardiol 2005;46:2204-2207.
4. Ellenbogen KA, Wood MA, Klein HU. Why should we care about CARE-HF?J Am Coll Cardiol 2005;46:2199-2203.
5. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-1365.
6. TeerlinkJR,Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, Packer M, Massie BM. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Promise (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 2000;101:40-46.
7. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, Dubner S, Scapin O, Perrone SV. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICAGEMA Investigators. Circulation 1996;94:3198-3203.
8. Defaye P, Leclercq JF, Guilleman D, Scanu P, Hazard JR, Fatemi M, Boursier M, Lambiez M. Contributions of high resolution electrograms memorized by DDR pacemakers in the interpretation of arrhythmic events. Pacing Clin Electrophysiol 2003;26:214-220.
9. Arya A, Haghjoo M, Dehghani MR, Alasti M, Alizadeh H, Kazemi B, Sadr-Ameli MA. Effect of cardiac resynchronisation therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter- defibrillator. Heart Rhythm 2005;2:1094-1098.
10. Lunati M, Gasparini M, Bocchiardo M, Curnis A, Landolina M, Carboni A, Luzzi G, Zanotto G, Ravazzi P, Magenta G, Denaro A, Distefano P, Grammatico A. Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator. J Cardiovasc Electrophysiol 2006;17:1299-1306.
11. Grimm W, Hoffmann JJ, Muller HH, Maisch B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 2002;39:780-787.
12. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC Jr, American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/ AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161.
13. Remme WJ, Swedberg K, Task Force for the Diagnosis Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560.
14. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR, Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-1990.
15. Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003;92:1238- 1240.
16. Sociéte Française de Cardiologie. Indications of implantable cardioverter defibrillator. Arch du Coeur Vaiss 2000;93:1227-1232.
17. Fish JM, Brugada J, Antzelevitch C. Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol 2005;46:2340-2347.
18. Vandenbroucke JP. The making of STROBE. Epidemiology 2007;18:797-799.
19. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, on behalf of the CARE-HF Study Investigators. Longer-term effects of cardiac resynchronisation therapy on mortality in heart failure - the Cardiac Resynchronisation-Heart Failure (CARE-HF) trial extension phase. Eur Heart J 2006;27 :1928-1932.
20. Boriani G, Gasparini M, Lunati M, Santini M, Landolina M, Vincenti A, Curnis A, Bocchiardo M, Padeletti L, Biffi M, Allaria L, Denaro A. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. m Heart J 2006;152:527.e1-e11.
21. Guerra JM, Wu J, Miller JM, Groh WJ. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003;14:1245-1247.
22. Mykytsey A, Maheshwari P, Dhar G, Razminia M, Zheutlin T, Wang T, Kehoe R. Ventricular tachycardia induced by biventricular pacing in patient with severe ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2005;16: 655-658.
23. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadecha M, Desai S, Meyer DB, VENTAK CHF Investigators. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36:824-827.
24. Kowal RC, Wasmund SL, Smith ML, Sharma N, Carayannopoulos GN, Le B, Cogan J, Kizilbash AM, Joglar JA, Hamdan MH. Biventricular pacing reduces the induction of monomorphic ventricular tachycardia: a potential mechanism for arrhythmia suppression. Heart Rhythm 2004;1:295-300.
25. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronisation therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-2688.
26. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC Jr, ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. Circulation 2002;106:2145- 2161.
27. Remme WJ, Swedberg K, Task Force for the Diagnosis Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560.
28. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007; 28:2256-2295.
29. Katritsis DG, Camm AJ. Nonsustained ventricular tachycardia: where do we stand? Eur Heart J 2004;25:1093-1099.